Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Intellia Therapeutics, Inc. Income Statement Banner

Intellia Therapeutics, Inc. Income Statement

NTLA Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Total Revenue
0.0006.044M16.479M26.117M30.434M43.103M57.994M33.053M52.121M36.275M
Cost of Revenue
1.658M11.170M31.840M67.647M89.115M108.413M150.408M6.891M7.572M8.976M
Gross Profit
-1.657m-5.126m-15.361m-41.530m-58.681m-65.310m-92.414m26.162M44.549M27.299M
Operating Expense
12.651M19.453M48.638M95.672M121.304M149.471M194.577M300.903M510.285M551.566M
Operating Income
-5.226m-13.409m-32.159m-69.555m-90.870m-106.368m-136.583m-267.850m-458.164m-515.291m
Other Income Expense
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Total Other Income Expense
-9.082m0.000525.000K2.012M5.527M6.835M2.352M-42.000k-16.022m-15.733m
Pretax Income
-14.308m-13.409m-31.634m-67.543m-85.343m-99.533m-134.231m-267.892m-474.186m-481.192m
Tax Provision
0.000-1.012m-1.104m-2.994m5.527M-6.835m-8.663m-8.174m16.022M-49.732m
Net Income
-14.308m-12.397m-31.634m-67.543m-85.343m-92.698m-125.568m-259.718m-490.208m-481.192m
Basic EPS
-29.450-0.700-1.420-1.880-1.980-1.960-2.240-3.660-6.370-5.420
Diluted EPS
-29.450-0.700-1.420-1.880-1.980-1.960-2.240-3.660-6.370-5.420
Basic Average Shares
485.882K17.664M22.222M36.006M43.069M47.247M55.987M70.894M76.972M88.770M
Diluted Average Shares
485.882K17.664M22.222M36.006M43.069M47.247M55.987M70.894M76.972M88.770M
Total Expenses
14.309M19.453M48.638M95.672M121.304M149.471M194.577M300.903M510.285M551.566M
Interest Income
0.0000.000525.000K2.012M5.527M6.835M2.352M1.283M8.542M49.832M
Interest Expense
0.0000.0000.0000.0000.0000.0000.0000.0008.542M0.000
EBITDA
-5.221m-13.081m-32.159m-69.555m-90.870m-100.781m-136.583m-267.850m-444.679m-506.215m
Depreciation & Amortization
4.500K328.000K1.104M2.994M4.464M5.587M6.311M6.891M7.572M8.976M